Discussion On The Investment And The Value Assessment Of Biotechnology Patents Sharing

With the growing prosperity of the capital market, biotechnology patent is no longer justtraded in the form of transfer, more of as a capital investment to the capitalization operation ofenterprises, in accordance with the equity proportion in biotechnology patent industries toparticipate in the profit distribution.This paper makes the construction of biotechnologypatents sharing theoretical system as the main line. combining with the questionnaire,tries todiscribe biotechnology patent sharing from five aspects: the connotation of biotechnologypatents definition; implementation mechanism; investment model and case analysis; valueevaluation method and the staking in profit distribution between the two game participater.constructing the basic theoretical framework for biotechnology patent sharing,based in thestatus of biotechnology patents gaving some suggestions for the biotechnology patentssharing, Related content are as follows:(1) Connotation defining of Biotechnology patents sharing.this paper mainly expoudsconnotation of biotechnology patents sharing, definitudes the scope of biotechnology patentssubject and object,defines the rights and obligations of biotechnology patents subject.(2) the implementation mechanism of Biotechnology patents sharing.with the use ofquestionnaire,exploring the main motivation of biotechnology patents sharing from the followthree aspects:”analysis biotechnology patent implementation of economic subject”,”survey ofbiotechnology patents willingness to stake”,” the main factors influencing the biotechnologypatents to stake”.(3) The model of Biotechnology patent investment and case analysis.this paper dividesbiotechnology companies formed by biotechnology patents staking into two styles:endogenous and exogenous biotechnology companies, constructs specific biotechnologypatents sharing model for them,and analyzes the advantages and disadvantages of differentmodes combined with practical case.(4) Methods of Biotechnology patents staking in valuation.different value assessmentmodel are defined for endogenous biotechnology companies and exogenous biotechnologycompanies,they are cost method and the real options method.and describes the advantages anddisadvantages of the two valuation methods and key considerations.(5) Game analysis of profit distribution between the two sides. This chapter combinedwith game theory and cobb-douglas production function and other related theory to explorethe dynamic mechanism. the dynamic mechanism aimed at maximizing enterprise valuethrough determining the interests of both parties in proportion and continued investment to biotechnology companies.